Form 4: Abbott Laboratories CEO Sells Shares
Insider Transaction (Form 4)
Robert B Ford, CHAIRMAN AND CEO and a Director of Abbott Laboratories, sold 398,832 shares of common stock on August 25, 2026.
Summary
- Option exercise/conversion: acquired 151,869 Common shares without par value at $44.40 ($6,742,984) on August 25, 2026; holds 458,330 after (Direct).
- Option exercise/conversion: acquired 246,963 Common shares without par value at $59.94 ($14,802,962) on August 25, 2026; holds 705,293 after (Direct).
- Open-market sale: disposed of 218,535 Common shares without par value at $115.57 ($25,256,090) on August 25, 2026; holds 486,758 after (Direct).
- Open-market sale: disposed of 180,297 Common shares without par value at $116.19 ($20,948,708) on August 25, 2026; holds 306,461 after (Direct).
- Option exercise/conversion: disposed of 151,869 Option (right to buy) on August 25, 2026 (Direct).
- Option exercise/conversion: disposed of 246,963 Option (right to buy) on August 25, 2026 (Direct).
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $46,204,798 of stock on the open market.
Insider Transactions
Robert B Ford — Director, Officer (CHAIRMAN AND CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-25 | Option exercise/conversion | Common shares without par value | 151,869 | $44 | $6.7M | 458,330 |
| 2026-08-25 | Option exercise/conversion | Common shares without par value | 246,963 | $60 | $14.8M | 705,293 |
| 2026-08-25 | Open-market sale | Common shares without par value | 218,535 | $116 | $25.3M | 486,758 |
| 2026-08-25 | Open-market sale | Common shares without par value | 180,297 | $116 | $20.9M | 306,461 |
| 2026-08-25 | Option exercise/conversion | Option (right to buy) | 151,869 | — | — | 0 |
| 2026-08-25 | Option exercise/conversion | Option (right to buy) | 246,963 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-25 | Option exercise/conversion (151,869 shares) |
| 2026-08-25 | Option exercise/conversion (246,963 shares) |
| 2026-08-25 | Open-market sale (218,535 shares) |
| 2026-08-25 | Open-market sale (180,297 shares) |
| 2026-08-25 | Option exercise/conversion (151,869 shares) |
| 2026-08-25 | Option exercise/conversion (246,963 shares) |
Keywords
insider transaction, Form 4, ABT, ABBOTT LABORATORIES, bearish, Robert B Ford
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.